SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-17-261015
Filing Date
2017-08-17
Accepted
2017-08-17 16:16:27
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d432974ds3.htm S-3 264650
2 EX-4.6 d432974dex46.htm EX-4.6 293660
3 EX-5.1 d432974dex51.htm EX-5.1 23763
4 EX-12.1 d432974dex121.htm EX-12.1 23492
5 EX-23.1 d432974dex231.htm EX-23.1 1578
6 GRAPHIC g432974g38i82.jpg GRAPHIC 22361
7 GRAPHIC g432974img.jpg GRAPHIC 2447
8 GRAPHIC g432974img2.jpg GRAPHIC 1949
  Complete submission text file 0001193125-17-261015.txt   645513
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-220014 | Film No.: 171038815
SIC: 2834 Pharmaceutical Preparations